Related Experiment Videos
[Analysis of hemostatic abnormality in various disease using molecular-I. Liver disease]
Insights
Liver disease causes hemostatic abnormalities, with increased coagulation and fibrinolysis markers. Specific markers like Fibrinopeptide A (FPA) and B beta 15-42 sensitively indicate these changes and potential disseminated intravascular coagulation (DIC).
Area of Science:
- Biochemistry
- Hematology
- Pathophysiology
Context:
- Liver disease significantly impacts systemic hemostasis.
- Hemostatic abnormalities are common but complex in liver disease patients.
- Accurate assessment of hemostatic function is crucial for patient management.
Purpose:
- To investigate hemostatic abnormalities in liver disease using specific molecular markers.
- To identify sensitive markers for coagulation and fibrinolysis in liver disease.
- To explore the role of vessel wall markers and the potential complication of disseminated intravascular coagulation (DIC).
Summary:
- Coagulation markers like Thrombin-Antithrombin (TAT), Fibrinopeptide A (FPA), and Soluble Fibrin Monomer Complexes (SFMC) were generally elevated in liver disease, with FPA showing the highest sensitivity.
- Hyperfibrinolysis was indicated by increased B beta 15-42, while SFMC or Fibrin Degradation Products (FDP) suggested DIC.
- Tissue Plasminogen Activator (t-PA) and Thrombomodulin (TM) showed a high correlation, potentially increasing due to impaired clearance from liver dysfunction and endothelial injury.
Impact:
- This study provides a comprehensive molecular profiling of hemostatic disorders in liver disease.
- The findings facilitate a more practical visualization of hemostatic imbalances using radar charts.
- Improved understanding aids in the diagnosis and management of bleeding or thrombotic complications in liver disease.
Abstract:
We examined the hemostatic abnormality of liver disease using hemostatic molecular markers, i.e. TAT, FPA and SFMC for coagulation, B beta 15-42, FDP, D dimer and PIC for fibrinolysis, t-PA and TM for vessel wall. The molecular markers for coagulation were generally increased in cases of liver disease, which was most sensitively reflected by FPA. On the other hand, it was postulated that SFMC was a marker reflecting the complication of DIC in these cases. Hyperfibrinolysis of liver disease was sensitively reflected by the increase of B beta 15-42, and an occasional increase of SFMC or FDP was thought to indicate the complication of DIC in these cases. A high correlation was found between t-PA and TM. It was postulated that the increase of the both markers in liver disease was due to deteriorated clearance by liver dysfunction, although TM is regarded as a marker reflecting endothelial injury. It was expected that visualization of hemostatic disorder of liver disease was made practical with the use of radar chart of these molecular markers.